Global Whole Slide Imaging Market

Whole Slide Imaging Market Size, Share, Growth Analysis, By Technology(Scanners, IT Infrastructure, Viewer, Image Management System), By Application(Telepathology, Cytopathology, Immunohistochemistry, Hematopathology), By End User(Hospitals & Clinics, Pathology Laboratories, Academic & Research Institute, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2149 | Region: Global | Published Date: March, 2024
Pages: 219 | Tables: 93 | Figures: 72

Whole Slide Imaging Market Insights

Global Whole Slide Imaging Market size was valued at USD 543.72 million in 2022 and is poised to grow from USD 642.68 million in 2023 to USD 2448.68 million by 2031, growing at a CAGR of 18.2% in the forecast period (2024-2031).

Whole slide imaging products revolutionize digital pathology by providing advanced and enhanced diagnostic capabilities. Hospitals, pharmaceutical companies, biotechnological firms, pathological labs, and test centers are among the diverse users benefiting from this technology. In the early stages of medical imaging, a combination of microscopes and computers was used to capture composite slide images, but this process was time-consuming. To overcome this limitation, whole slide imaging emerged in the late 1990s, utilizing automated algorithms and high-speed systems to significantly improve image acquisition speed. This technological advancement has expanded the scope of applications for whole slide imaging.

In May 2021, recognizing the rapid advancements in clinical applications for whole slide imaging and digital pathology, the College of American Pathologists (CAP), along with the American Society for Clinical Pathology (ASCP) and the Association for Pathology Informatics (API), collaborated to update guidelines validating whole slide imaging for diagnostic purposes in pathology. These updated guidelines ensure that patients receive their pathologic diagnosis rapidly, maintaining the same level of quality in test results, enabling them to receive timely treatment. As the technology continues to evolve, driving increased accuracy and efficiency in diagnostics, the whole slide imaging market is poised for significant growth. The advancements in whole slide imaging technology are transforming the field of pathology and empowering healthcare providers with faster, more precise diagnostic capabilities for better patient outcomes.

US Whole Slide Imaging Market is poised to grow at a sustainable CAGR for the next forecast year.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Whole Slide Imaging Market size was valued at USD 543.72 million in 2022 and is poised to grow from USD 642.68 million in 2023 to USD 2448.68 million by 2031, growing at a CAGR of 18.2% in the forecast period (2024-2031).

The whole slide imaging (WSI) market features a highly competitive landscape with several key players vying for market share. Companies in this market are primarily focused on technological advancements, product innovation, strategic collaborations, and mergers and acquisitions to gain a competitive edge. Leading players such as Danaher Corporation, Hamamatsu Photonics K.K., 3DHISTECH Ltd., and Olympus Corporation are known for their strong presence and extensive product portfolios. 'Danaher Corporation (United States)', 'Hamamatsu Photonics K.K. (Japan)', '3DHISTECH Ltd. (Hungary)', 'Olympus Corporation (Japan)', 'Roche Holding AG (Switzerland)', 'Koninklijke Philips N.V. (Netherlands)', 'Leica Biosystems Nussloch GmbH (Germany)', 'Ventana Medical Systems, Inc. (United States)', 'PerkinElmer, Inc. (United States)', 'Sectra AB (Sweden)', 'Diasorin (Italy)', 'NanoString Technologies (United States)', 'Biocare Medical (United States)', 'Sakura Finetek (Japan)', 'DigiPath (United States)', 'Indica Labs (Canada)'

The increasing incidence of chronic diseases, such as cancer, requires accurate and efficient diagnostic tools, making Whole Slide Imaging an essential technology for pathology labs and healthcare providers.

Integration with Laboratory Information Systems (LIS): Integration of Whole Slide Imaging systems with LIS and electronic health record (EHR) systems streamlines the workflow and facilitates seamless data management, enabling efficient patient record-keeping.

North America is projected to hold the highest market share in the whole slide imaging market during the forecast period. This dominance is driven by the increasing incidence of cancer and the growing adoption of digital pathology to enhance laboratory efficiency in the region. Notably, the American Cancer Society estimates around 1.9 million new cancer cases and 609,360 cancer-related deaths in the United States in 2022. The rising cancer burden is expected to lead to a surge in the demand for diagnostic laboratories and consequently accelerate market expansion in North America.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Whole Slide Imaging Market

Report ID: SQMIG35D2149

$5,300
BUY NOW GET FREE SAMPLE